Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1964 2
1965 1
1966 3
1967 4
1968 2
1969 3
1970 2
1971 1
1972 2
1973 1
1974 5
1975 4
1976 8
1977 14
1978 12
1979 9
1980 12
1981 2
1982 6
1983 4
1984 6
1985 12
1986 4
1987 8
1988 13
1989 8
1990 6
1991 5
1992 4
1993 15
1994 18
1995 19
1996 5
1997 13
1998 14
1999 10
2000 13
2001 6
2002 8
2003 11
2004 9
2005 11
2006 9
2007 11
2008 10
2009 5
2010 5
2011 8
2012 9
2013 12
2014 10
2015 15
2016 14
2017 11
2018 8
2019 18
2020 23
2021 25
2022 30
2023 24
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

535 results

Results by year

Filters applied: . Clear all
Page 1
Cellular senescence induction leads to progressive cell death via the INK4a-RB pathway in naked mole-rats.
Kawamura Y, Oka K, Semba T, Takamori M, Sugiura Y, Yamasaki R, Suzuki Y, Chujo T, Nagase M, Oiwa Y, Fujioka S, Homma S, Yamamura Y, Miyawaki S, Narita M, Fukuda T, Sakai Y, Ishimoto T, Tomizawa K, Suematsu M, Yamamoto T, Bono H, Okano H, Miura K. Kawamura Y, et al. Among authors: nagase m. EMBO J. 2023 Aug 15;42(16):e111133. doi: 10.15252/embj.2022111133. Epub 2023 Jul 11. EMBO J. 2023. PMID: 37431790 Free article.
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).
Yamazaki K, Nagase M, Tamagawa H, Ueda S, Tamura T, Murata K, Eguchi Nakajima T, Baba E, Tsuda M, Moriwaki T, Esaki T, Tsuji Y, Muro K, Taira K, Denda T, Funai S, Shinozaki K, Yamashita H, Sugimoto N, Okuno T, Nishina T, Umeki M, Kurimoto T, Takayama T, Tsuji A, Yoshida M, Hosokawa A, Shibata Y, Suyama K, Okabe M, Suzuki K, Seki N, Kawakami K, Sato M, Fujikawa K, Hirashima T, Shimura T, Taku K, Otsuji T, Tamura F, Shinozaki E, Nakashima K, Hara H, Tsushima T, Ando M, Morita S, Boku N, Hyodo I. Yamazaki K, et al. Among authors: nagase m. Ann Oncol. 2016 Aug;27(8):1539-46. doi: 10.1093/annonc/mdw206. Epub 2016 May 13. Ann Oncol. 2016. PMID: 27177863 Free article. Clinical Trial.
Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial.
Hironaka S, Ueda S, Yasui H, Nishina T, Tsuda M, Tsumura T, Sugimoto N, Shimodaira H, Tokunaga S, Moriwaki T, Esaki T, Nagase M, Fujitani K, Yamaguchi K, Ura T, Hamamoto Y, Morita S, Okamoto I, Boku N, Hyodo I. Hironaka S, et al. Among authors: nagase m. J Clin Oncol. 2013 Dec 10;31(35):4438-44. doi: 10.1200/JCO.2012.48.5805. Epub 2013 Nov 4. J Clin Oncol. 2013. PMID: 24190112 Clinical Trial.
Recent topics on podocytes and aldosterone.
Nagase M. Nagase M. J Ren Nutr. 2015 Mar;25(2):201-4. doi: 10.1053/j.jrn.2014.10.016. Epub 2014 Dec 12. J Ren Nutr. 2015. PMID: 25499230 Review.
Another mechanism of atrial fibrillation initiation?
Nakashima T, Nagase M, Shibahara T, Ono D, Yamada T, Tanabe G, Suzuki K, Yamaura M, Ido T, Takahashi S, Aoyama T. Nakashima T, et al. Among authors: nagase m. J Cardiovasc Electrophysiol. 2021 Jul;32(7):1979-1981. doi: 10.1111/jce.15110. Epub 2021 May 30. J Cardiovasc Electrophysiol. 2021. PMID: 34031934 No abstract available.
[Mesangial proliferative glomerulonephritis].
Kaneko O, Akimoto H, Nagase M. Kaneko O, et al. Among authors: nagase m. Ryoikibetsu Shokogun Shirizu. 1997;(16 Pt 1):215-8. Ryoikibetsu Shokogun Shirizu. 1997. PMID: 9277725 Review. Japanese. No abstract available.
Electrocardiographic features of paradoxical ventriculophasic response.
Nakashima T, Nagase M, Shibahara T, Ono D, Yamada T, Tanabe G, Suzuki K, Yamaura M, Ido T, Takahashi S, Okura H, Aoyama T. Nakashima T, et al. Among authors: nagase m. J Electrocardiol. 2022 Mar-Apr;71:67-73. doi: 10.1016/j.jelectrocard.2022.02.002. Epub 2022 Feb 12. J Electrocardiol. 2022. PMID: 35183045
Message From an Automated External Defibrillator.
Nagase M, Nakashima T, Aoyama T. Nagase M, et al. JAMA Intern Med. 2024 Apr 29. doi: 10.1001/jamainternmed.2023.7879. Online ahead of print. JAMA Intern Med. 2024. PMID: 38683588
Hedgehog signalling in vascular development.
Nagase T, Nagase M, Machida M, Fujita T. Nagase T, et al. Among authors: nagase m. Angiogenesis. 2008;11(1):71-7. doi: 10.1007/s10456-008-9105-5. Angiogenesis. 2008. PMID: 18301996 Review.
535 results